Device maker looks to apply fluorescence to skin cancer detection

03/12/2013 | BioOptics World

LED Medical Diagnostics is testing tissue fluorescence technology to identify skin cancer and define surgical margins for the excision of basal cell carcinoma and squamous cell carcinoma. The company's VELscope is already FDA-approved to help determine surgical margins with cancers and precancerous lesions of the mouth.

View Full Article in:

BioOptics World

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA